TY - JOUR T1 - Genomic Characterization of Posttraumatic Stress Disorder in a Large US Military Veteran Sample JF - bioRxiv DO - 10.1101/764001 SP - 764001 AU - Murray B. Stein AU - Daniel F. Levey AU - Zhongshan Cheng AU - Frank R. Wendt AU - Kelly Harrington AU - Kelly Cho AU - Rachel Quaden AU - Krishnan Radhakrishnan AU - Matthew J. Girgenti AU - Yuk-Lam Anne Ho AU - Daniel Posner AU - PTSD Working Group of the Psychiatric Genomics Consortium (PGC) AU - Traumatic Stress Brain Research Study Group AU - VA Million Veteran Program AU - VA Cooperative Studies Program AU - Mihaela Aslan AU - Ronald S. Duman AU - Hongyu Zhao AU - Renato Polimanti AU - John Concato AU - Joel Gelernter Y1 - 2019/01/01 UR - http://biorxiv.org/content/early/2019/09/10/764001.abstract N2 - Individuals vary in their liability to develop Posttraumatic Stress Disorder (PTSD), the symptoms of which are highly heterogeneous, following exposure to life-threatening trauma. Understanding genetic factors that contribute to the biology of PTSD is critical for refining diagnosis and developing new treatments. Using genetic data from more than 250,000 participants in the Million Veteran Program, genomewide association analyses were conducted using a validated electronic health record-based algorithmically-defined PTSD diagnosis phenotype (48,221 cases and 217,223 controls), and PTSD quantitative symptom phenotypes (212,007 individuals). We identified several genome-wide significant loci in the case-control analyses, and numerous such loci in the quantitative trait analyses, including some (e.g., MAD1L1; TCF4; CRHR1) that were associated with multiple symptom sub-domains and total symptom score, and others that were more specific to certain symptom sub-domains (e.g., CAMKV to re-experiencing; SOX6 to hyperarousal). Genetic correlations between all pairs of symptom sub-domains and their total were very high (rg 0.93 – 0.98) supporting validity of the PTSD diagnostic construct. We also demonstrate strong shared heritability with a range of traits, show that heritability persists when conditioned on other major psychiatric disorders, present independent replication results, provide support for one of the implicated genes in postmortem brain of individuals with PTSD, and use this information to identify potential drug repositioning candidates. These results point to the utility of genetics to inform and validate the biological coherence of the PTSD syndrome despite considerable heterogeneity at the symptom level, and to provide new directions for treatment development. ER -